Consistent with this, phenformin, unlike rapamycin, increased the cellular ADP:ATP ratios in all three T-ALL cell lines and increased apoptosis in an AMPK-dependent manner in lymphoma cells in vivo. This evidence concerns the gene PRKAA1 and acute lymphoblastic leukemia.